

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Crohn disease | D003424 | EFO_0000384 | K50 | — | 2 | — | — | — | 2 |
| Celiac disease | D002446 | EFO_0001060 | K90.0 | — | 1 | — | — | — | 1 |
| Drug common name | Vercirnon |
| INN | vercirnon |
| Description | Vercirnon is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against C-C chemokine receptor type 9. |
| Classification | Small molecule |
| Drug class | Chemokine receptor (CCR) antagonists, not antivirals |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1 |
| PDB | — |
| CAS-ID | 698394-73-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2178578 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | MWI54OUA12 (ChemIDplus, GSRS) |
